CEO 360 Degree Perspective - Global Pharmaceuticals & Biotechnology Industry

CEO 360 Degree Perspective - Global Pharmaceuticals & Biotechnology Industry

 

RELEASE DATE
29-Jul-2009
REGION
Global
Deliverable Type
Market Research
Research Code: N5DC-01-00-00-00
SKU: HC02121-GL-MR_07632
AvailableYesPDF Download
$4,950.00
In stock
SKU
HC02121-GL-MR_07632
$4,950.00
DownloadLink
ENQUIRE NOW

Description

This research service presents the CEO 360 Degree Perspective for the global pharmaceuticals and biotechnology industry in 2009. It is an amalgamation of research from more than 50 Pharmaceutical research services generated by Frost & Sullivan, customer research findings based on approximately 1,000 end-user interviews approximately 50,000 hours of analyst research, in the last 2 years. Global healthcare analysts from Frost & Sullivan have contributed their market knowledge to cover the most important issues that are relevant in the healthcare industry today. The report also includes research findings from econometric, advanced technology and several other business divisions of Frost & Sullivan.

Table of Contents

Introduction

  • Title
  • Disclaimer
  • Certification
  • Research Overview and Background
  • 360 Degree Perspective and the Complex Business Universe
  • Table of Contents

Global Perspective

  • Global Perspective
  • Shifting Global Clinical Trial Dynamics
  • Shift In Growth From Mature Markets To Emerging Markets

Integrated Industry Perspective

  • Integrated Industry Perspective
  • Adaptation To Changing Business Models
  • Consolidation of Pfizer and Wyeth
  • Convergence of Healthcare Allows for Personalization
  • Move from Transactional to Strategic Outsourcing Partnerships Encourages Standardization of LIMS

Technology Perspective

  • Technology Perspective
  • Oral Oncology Drugs Increasing in Importance
  • Advances in Genomics Promotes Healthcare Paradigm Shift
  • Effective Screening Methods to Select the Most Promising Drug Candidates
  • Growth of Vaccines Market Boosting Technology Innovation
  • Gene Therapy Driving Market

Economic Perspective

  • Economic Perspective
  • Venture Capital Investment in U.S. Biotechnology has Decreased to Levels Not Seen Since 2002
  • Decreasing Number of Biotech IPO's due to Economic Downturn
  • Restructuring
  • Continued Healthcare Spending Growth

Competitive Perspective

  • Competitive Perspective
  • Companies Transforming to Comprehensive Solution Providers
  • Repositioning of Platform Technology Providers in Response to Biomarker Discovery and Diagnostics Development
  • Expansion of Biosimilars Alters Industry Landscape

Customer Perspective

  • Customer Perspective
  • Power Patient Generation
  • eDetailing To Assume More Significance
  • Medical Tourism – Emerging Hot Spots

Best Practices Perspective

  • Best Practices Perspective
  • Green Chemistry Initiatives
  • Focus on Diseases with High Unmet Needs and Special Designations
  • Lower Cost Drugs for Developing Countries
  • Employing Hybrid Business Models

About Frost & Sullivan

  • Frost & Sullivan
This research service presents the CEO 360 Degree Perspective for the global pharmaceuticals and biotechnology industry in 2009. It is an amalgamation of research from more than 50 Pharmaceutical research services generated by Frost & Sullivan, customer research findings based on approximately 1,000 end-user interviews approximately 50,000 hours of analyst research, in the last 2 years. Global healthcare analysts from Frost & Sullivan have contributed their market knowledge to cover the most important issues that are relevant in the healthcare industry today. The report also includes research findings from econometric, advanced technology and several other business divisions of Frost & Sullivan.
More Information
Deliverable Type Market Research
No Index Yes
Podcast No
Industries Healthcare
WIP Number N5DC-01-00-00-00
Is Prebook No